United States Antimony is trading now at $2.65, down 11.09%; broad market weakness is the clearest available context for the decline.
- No company-specific catalyst directly explaining the drop was established.
- A November 5 article mentioned the company’s Nolan Creek project but did not link the news to the stock move.
- Major U.S. indexes were reported lower amid concerns about AI regulation, technology weakness and interest rates.